Advanced Medical Solutions GroupCHIX:AMSL -0.36%93 Return-on-Tangible-Asset is 4.01% as of Dec. 2025, which is 69% below its 10-year median of 13.05. GuruFocus rates CHIX:AMSL with a GF Score™ of 93/100 and a GF Value™ of £3.72 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Advanced Medical Solutions Group ranks better than 67.33% on this metric.
The historical rank and industry rank for Advanced Medical Solutions Group's Return-on-Tangible-Asset or its related term are showing as below:
CHIX:AMSl'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 4.34 Med: 13.05 Max: 19.51
Current: 5.45
During the past 13 years, Advanced Medical Solutions Group's highest Return-on-Tangible-Asset was 19.51%. The lowest was 4.34%. And the median was 13.05%.
CHIX:AMSl's Return-on-Tangible-Asset is ranked better than 67.33% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 0.665
vs CHIX:AMSl: 5.45
Advanced Medical Solutions Group (CHIX:AMSl) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Advanced Medical Solutions Group Return-on-Tangible-Asset Related Terms
Advanced Medical Solutions Group Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Medical Solutions Group Return-on-Tangible-Asset Chart
CHIX:AMSL vs ISRG, BDX, MDLN: Return-on-Tangible-Asset Comparison
For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Medical Solutions Group Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Advanced Medical Solutions Group's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of 4.01% mean?
Advanced Medical Solutions Group (CHIX:AMSL) has a Return-on-Tangible-Asset of 4.01% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Advanced Medical Solutions Group and its competitors. This is 69% below median its historical median of 13.05. Over the past decade, Advanced Medical Solutions Group's Return-on-Tangible-Asset has ranged from 4.34 to 19.51. According to the industry distribution chart, Advanced Medical Solutions Group ranks #279 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 32.7%.
Is Advanced Medical Solutions Group's Return-on-Tangible-Asset too high?
Advanced Medical Solutions Group's current Return-on-Tangible-Asset of 4.01% is 69% below median its 10-year median of 13.05. Over the past 10 years, this metric has ranged from a low of 4.34 to a high of 19.51. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.67. Advanced Medical Solutions Group's value of 4.01% is 503% above this industry median. Based on the distribution chart, Advanced Medical Solutions Group ranks #279 out of 854 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Advanced Medical Solutions Group has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Solutions Group's Return-on-Tangible-Asset compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Advanced Medical Solutions Group ranks #279 out of 854 companies for Return-on-Tangible-Asset. This puts Advanced Medical Solutions Group in the upper half of its industry. The industry median Return-on-Tangible-Asset is 0.67. Advanced Medical Solutions Group's value of 4.01% is 503% above this benchmark. Historically, Advanced Medical Solutions Group's own Return-on-Tangible-Asset has ranged from 4.34 to 19.51 over the past decade. While the company's 10-year median is 13.05 vs. the industry median of 0.67, Advanced Medical Solutions Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.67, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Advanced Medical Solutions Group's current Return-on-Tangible-Asset of 4.01% is 503% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Advanced Medical Solutions Group and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Medical Solutions Group's current Return-on-Tangible-Asset is 4.01%, which is 69% below median its own 10-year median of 13.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Solutions Group stock overvalued right now?
Based on GuruFocus' analysis, Advanced Medical Solutions Group (CHIX:AMSL) is currently considered Modestly Undervalued. The stock's GF Value™ is £3.72, compared to a current price of £2.79 — trading 25.1% below its estimated fair value. The current Return-on-Tangible-Asset is 4.01%, which is 69% below median its 10-year median of 13.05 and 503% above the Medical Devices & Instruments industry median of 0.67. Advanced Medical Solutions Group's overall GF Score™ is 93/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Advanced Medical Solutions Group (CHIX:AMSL), the current Return-on-Tangible-Asset is 4.01% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Advanced Medical Solutions Group (CHIX:AMSL) Overvalued in 2026?
Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued.
The current stock price of £2.79 is trading 25.1% below its estimated GF Value™ of £3.72.
GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.
Key valuation signals for CHIX:AMSL:
Return-on-Tangible-Asset: 4.01% (69% below median its 10-year median of 13.05)
GF Value™: £3.72 vs. price of £2.79 (25.1% below fair value)
Industry Position: 503% above the Medical Devices & Instruments median (#279 of 854)
No single metric tells the full story. See the CHIX:AMSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Advanced Medical Solutions Group Business Description
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
93GF Score
Get the complete analysis for CHIX:AMSL
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMSL has been successfully added to your 
